1
Nov 16 (Reuters) – Clearmind Medicine Inc: * CLEARMIND ACHIEVES FULL ENROLLMENT FOR PART C IN CMND-100 PHASE I/IIA TRIAL, MARKING KEY CLINICAL MILESTONE Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)